<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/201460-a-film-coated-tablet-with-cyclophosphamide-as-active-compound by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 01:31:22 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 201460:A FILM COATED TABLET WITH CYCLOPHOSPHAMIDE AS ACTIVE COMPOUND</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">A FILM COATED TABLET WITH CYCLOPHOSPHAMIDE AS ACTIVE COMPOUND</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>A film-coated tablet with cyclophosphamide as active compound, comprising in the core cyclophosphamide, one or more fillers selected from the group consisting of lactose monohydrate, D-mannitol and CaHPO4, one or more dry binders selected from the group consisting of nonpreswollen corn starch and microfine cellulose, highly disperse silica as flow regulator, and a lubricant selected from the group consisting of magnesium stearate, stearic acid, glycerol palm ito stearate, polyethylene glycol, talcum and glycerol monobehenate, wherein the core can comprise the auxiliaries either individually or alternatively in any desired mixture.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>WO 99/65499	PCT/EP99/03920<br>
Cyclophosphamide film-coated tablets<br>
The invention relates to cyclophosphamide film-coated tablets and to a process for their preparation. The invention can be used in the pharmaceutical industry.<br>
Cyclophosphamide is an agent haying a broad antitumor spectrum which has been introduced in chemotherapy for decades for . the treatment of solid tumors" such as breast carcinoma, bronchial carcinoma and hemoblastoses.<br>
Until now, known pharmaceutical forms have been tablets, coated tablets and mainly lyophilizates with various auxiliaries such as mannitol or urea.<br>
EP 0519099 describes tablets comprising cyclophosphamide and preswollen starch, prepared by a direct tableting process.<br>
Since cyclophosphamide is harmful to health and for this reason direct contact with this substance represents a potential risk, the tablets prepared according to EP 0519099 are used as cores for press-coated tablets and. thus coated by means of a second tablet ing. This process is technically complicated. Special tableting machines are furthermore needed for the preparation of press-coated tablets.<br>
The need thus exists for a simple and economical preparation of solid pharmaceutical form [sic] comprising cyclophosphamide for oral administration. It is necessary to take into consideration here that the pharmaceutical forms have to be coated in order that direct contact with the cytotoxic active compound is avoided.<br>
It is moreover known that eyclophosphamide is chemically   labile,   thus   the   stability   of   the<br><br>
WO 99/65499	PCT/EP99/03920<br>
	- 2 -              <br>
pharmaceutical	forms  must  also  be  taken  into<br>
consideration.<br>
Surprisingly, it has been possible to prepare film-coated tablets comprising cyclophosphamide without the use of preswollen starch.<br>
Suitable auxiliaries were selected on the basis of the compatibility investigations mentioned in Example I [sic] . It was surprising in this context that the stability of cyclophosphamide is somewhat indifferent in the presence of preswollen starch.<br>
It was moreover surprising that the finished film-coated tablets exhibit an adeoua.te stability although the active  compound,  due  to  the  preparation   is<br>
stressed during the film-coating process	by moisture<br>
and heat<br>
Example 1<br>
Investigations on the compatibility of cyclophosphamide<br>
with various tableting auxiliaries<br>
53.5 mg of cyclophosphamide and 86.5 mg of (auxiliary 1-10) [sic] or 3.0 mg of (auxiliary 11-18) [sic] were in each case mixed, and compressed. The. pressed tablets were stored at 31°C for 6 months. The decomposition of the active compound took place [sic] by means of chloride determination. The results are summarized in the following table.<br><br>
WO   99/65499	PCT/EP99/03920<br>
	-   3   -	<br><br>
Function of the auxiliary<br><br>
Auxiliary<br>
Decomposition of cyclo-phosphamide<br>
Dis-coloration<br>
FILLER<br>
1<br>
Lactose, anhydrous<br>
2.52<br>
++<br><br>
2<br>
Calcium phosphate<br>
3.85<br>
-<br><br>
3<br>
Calcium phosphate anhydrous<br>
2.02<br>
-<br><br>
4<br>
Emcompress (CaHPO4)<br>
1.50<br><br><br>
5<br>
D-mannitol<br>
1.15<br>
-<br><br>
6<br>
Lactose monohydrate<br>
0.70<br>
-<br>
FILLER/DRY BINDER/<br>
7<br>
Microcrystalline cellulose<br>
1.50-1.73*<br>
-<br>
DISINTEGRATION<br>
8<br>
Cellulose (Elcema)<br>
0.85-1.32*<br>
- +<br>
PROMOTER<br>
9<br>
Preswollen starch .<br>
1.02<br>
- +<br><br>
10<br>
Corn starch<br>
0.75<br>
-<br>
DISINTEGRATION PROMOTER<br>
11<br>
Crosslinked poly-vinylpyrrolidone<br>
1.5<br>
+ +<br>
FLOW REGULATOR<br>
12<br>
Highly disperse silica<br>
0.46-1.72*<br>
- +<br>
FLOW REGULATOR/<br>
13<br>
Magnesium sterate [sic]<br>
1.51<br>
- +<br>
LUBRICANT<br>
14<br>
Stearic acid<br>
0.94<br>
- +<br><br>
15<br>
Glycerol palmitostearate<br>
0.82<br>
-<br><br>
16<br>
Polyethylene glycol<br>
0.68<br>
-<br><br>
17<br>
Talc<br>
0.55<br>
-<br><br>
18<br>
Glycerol monobeherate [sic]<br>
0.30<br>
-<br>
Dependent   on   type<br><br>
WO  99/65499	PCT/EP99/03920<br>
-   4   -	<br>
Example 2<br>
Preparation of tablet cores (50 mg of cyclophosphamide) Direct tableting<br>
0.535 mg  of  cyclophosphamide,  0.390 mg  of  lactose<br>
monohydrate, 0.400 mg of microfine cellulose, 0.200 mg of corn starch, 0.040 mg of talc and 0.020 mg of highly disperse silica are sieved and homogenized. 0.015 mg of magnesium stearate is then added and mixed. The mass prepared in'this way is processed to give tablets:<br>
Weight:	160 mg<br>
Hardness:        &gt; 30 N Disintegration:  
Example 3<br>
Preparation   of   film-coated   tablets   (50 mg   of eye1opho sphami de)<br>
11.83 g of polyethylene glycol and 2.37 g of polysorbate 80 are dissolved in 75.21 g of water. 1.9 g of carboxymethylcellulose sodium are dissolved in 80.0 g of water. The solutions are brought together. 23.67 g of talc, 23.67 g of titanium dioxide and 0.24 g of simeticone [sic] are then added and the mixture is homogenized. 17.73 g of a 30% strength ethyl acrylate/methyl metharcrylate [sic] copolymer dispersion in water are then added. The tablet cores are then sprayed with the prepared suspension in a suitable apparatus:<br>
Theoretical weight of a film-coated tablet:  166 mg<br><br>
WO 99/65499	PCT/EP99/03920<br>
_ 5 _<br>
Example 4<br>
Investigation  of  the  stability  of  cyclophosphamide film-coated tablets<br><br>
Decomposition of<br>
cyclophosphamide<br>
after<br>
3 months<br><br><br>
26°C/60% RH<br><br>
3<br>
l°C/40%<br>
Batch 1<br><br>
0.30<br><br>
.4<br>
.12<br>
Batch 2<br><br>
0.17<br><br>
2<br>
.36<br>
Stability of the film-coated tablets of ,up-_to_3_ years is expected on storage at 
<br>
-6-<br>
1. A  film-coated  tablet  with   cyclophosphamide   as   active   compound,<br>
comprising in the core cyclophosphamide, one or more fillers selected<br>
from  the group consisting of lactose monohydrate, D-mannitol and<br>
CaHPO4, one or more dry binders selected from the group consisting of<br>
nonpreswollen  corn  starch and micro fine cellulose, highly disperse<br>
silica as  flow regulator,  and a lubricant selected from   the group<br>
consisting of magnesium s tear ate, stearic acid, glycerol palmitostearate,<br>
polyethylene glycol, talcum and glycerol monobehenate, wherein the<br>
core can comprise the auxiliaries either individually or alternatively in<br>
any desired mixture.<br>
2. The film-coated tablet as claimed in claim 1&gt; comprising, per 1 part of<br>
cyclophosphamide   in    the   core,   lactose   monohydrate,   micro fine<br>
cellulose, nonpreswollen corn starch, talcum, highly disperse silica and<br>
magnesium stearate in the following ratio.<br>
lactose monohydrate 0.2-1.5, preferably 0.5-1, particularly 0.73; microfme cellulose 0.2-1.5, preferably 0.5-1, particularly 0.74; nonpreswollen corn starch 0.1-1.5, preferably 0.2-0.7, particularly 0.37; talcum 0.01-1.5, preferably 0.05-0.08, particularly 0.07; highly disperse silica 0.01-0.1, preferably 0.01-0.5, particularly 0.04; magnesium stearate 0.01-0.,l preferably 0.01-0.05, particularly 0.03.<br>
3.	The film-coated tablet as claimed in claim 1 or 2, wherein the core<br><br>
-7-<br>
comprises 50.0 mg cyclophosphamide (53.5 mg cyclophosphamide monohydrate), 39.0 mg lactose monohydrate, 20.0 mg nonpreswollen corn starch, 40.0 mg microfine cellulose, 2.0 mg highly disperse silica, 4.0 mg talcum, and 1.5 mg magnesium stearate.<br>
4. A method for manufacturing of tablet cores suitable to be provided with<br>
a   film   coat,   wherein   the   steps   that   cyclophosphamide,   lactose<br>
monohydrate, microfine cellulose, nonpreswollen corn starch, talcum<br>
and highly disperse silica are sieved and homogenized, then magnesium<br>
stearate is added and mixed, and the so obtained mass is pressed into<br>
tablet cores.<br>
5. The method as claimed in claim 4, wherein in the core the amount of<br>
lactose monohydrate, microfine cellulose, nonpreswollen corn starch,<br>
talcum, highly disperse silica aad magnesias stearate, per 1 part of<br>
cyclophosphamide, is as follows:<br>
lactose monohydrate 0.2-1.5, preferably 0.5-1, particularly 0.73; microfme cellulose 0,2-1.5, preferably 0.5-1, particularly 0.74; nonpreswollen corn starch 0.1-1.5, preferably 0.2-0.7, particularly 0.37; talcum 0.01-1,5, preferably 0.05-0,08, particularly 0.07; highly disperse silica 0.01-0.1, preferably 0.01-0.5, particularly 0.04; magnesium stearate 0.01-0.1, preferably 0.01-0.05, particular^ 0.03.<br><br>
-8-<br>
6. The method as claimed in claim 4 or 5, wherein the core contains 50.0<br>
mg cyclophosphamide (53.5 rag cyclophosphamide monohydrate), 39.0<br>
mg lactose monohydrate, 20.0 mg nonpreswollen corn starch, 40.0 mg<br>
microfine cellulose, 2.0 mg highly dispersed silica, 4.0 mg talcum, and<br>
1.5 mg magnesium stearate.<br>
7. A process for manufacturing a film-coated tablet, wherein the tablet<br>
cores obtained as claimed in anyone of claims 4 to 6 are sprayed with a<br>
suspension obtained by dissolving of 11.83 g polyethylene glycol and<br>
2.37    g    poly sorb ale    80    in    water,    further   dissolving    of   1.9   g<br>
carboxymethylceliulose sodium in 80.0 g water, then bringing the two<br>
solutions together, adding of 23.67 g talcum, 23.67 g titanium dioxide<br>
and 0.24 g simeticone thereto, then homogenizing, then adding of 17.73<br>
g of a 30% ethyl acrylate-m ethyl meth aery late copolymer dispersion<br>
thereto.<br>
8. A tablet core obtained by the process as claimed in anyone of claims 4<br>
to 6.<br>
9. A film coated tablet obtained by the process as claimed in claim 7.<br>
A film-coated tablet with cyclophosphamide as active compound, comprising in the core cyclophosphamide, one or more fillers selected from  the group  consisting of lactose monohydrate, D-mannitol and CaHPO4, one or more dry binders selected from the group consisting of nonpreswollen  corn  starch and microfine cellulose, highly disperse silica as  flow regulator,  and a lubricant selected from   the group consisting of magnesium stearate, stearic acid, glycerol palm ito stearate, polyethylene glycol, talcum  and glycerol monobehenate, wherein the core can comprise the auxiliaries either individually or alternatively in any desired mixture.<br><br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
		<br>
		<div class="pull-left">
			<a href="201459-regents-and-methods-for-detecting-a-reduced-cofactor.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="201461-a-vehicle-driven-by-human-effort.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>201460</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>IN/PCT/2000/00552/KOL</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>08/2007</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>23-Feb-2007</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>23-Feb-2007</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>23-Nov-2000</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>ASTA MEDICA AKTIENESLLSCHAFT</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>AN DER PIKARDIE 10, D-01277 DRESDEN, GERMANY</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>RAWERT JURGEN</td>
											<td>BEZIRKSSTRASSE 27, D-63755 ALZENAU, GERMANY</td>
										</tr>
										<tr>
											<td>2</td>
											<td>SAUERBIER DIETER</td>
											<td>RAUHE HORST 18, D-33824 WERTHER, GERMANY</td>
										</tr>
										<tr>
											<td>3</td>
											<td>WICHERT BURKHARD</td>
											<td>ROONSTRASSE 48, D-33615 BIELEFELD, GERMANY</td>
										</tr>
										<tr>
											<td>4</td>
											<td>ENGEL JURGEN</td>
											<td>ERLENWEG 3, D-63755 ALZENAU, GERMANY</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A 61K 9/28;</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP99/03920</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>1999-06-08</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>198 26 517.4</td>
									<td>1998-06-15</td>
								    <td>Germany</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/201460-a-film-coated-tablet-with-cyclophosphamide-as-active-compound by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 01:31:23 GMT -->
</html>
